<p>The National Heart Lung and Blood Institute awarded a $39,200 purchase order to EMD Millipore Corp on June 25, 2013, for maintenance of an Amnis ImageStream flow cytometry system supporting cell biology research at the Laboratory of Flow Cytometry Core Facility in Bethesda, Maryland. The order carries a firm fixed price, with ultimate completion on September 29, 2014. No set-aside applied.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to EMD Millipore Corp for $41,050.00 on September 25, 2014, with completion by December 21, 2014. The order carries no set-aside designation and is priced on a firm fixed price basis. Work is performed in Billerica, Massachusetts. The source does not specify the goods or services procured under this order.</p>
This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to EMD Millipore Corp, a foreign-owned, for-profit manufacturer of laboratory products and services. The $113,054.40 contract is for a one-year service plan covering an AMNIS ImageStreamX flow cytometry system used in biomedical research, with a potential period of performance through September 2021. There is no set-aside designation for this...
This is a $83,771.00 fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to EMD Millipore Corp. The contract is for the provision of a service maintenance agreement for an Amnis ImageStream Mk II flow cytometry system, including catalog items, over a multi-year period. EMD Millipore Corp is a foreign-owned, for-profit manufacturer that supplies a wide range...
EMD Millipore Corporation was awarded a Firm Fixed Price BPA Call contract worth $4,116.13 by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to provide service and maintenance for flow cytometry lab equipment. The contract period of performance was from February 26, 2016 to February 25, 2017. This contract was not set aside for any specific business category. EMD Millipore Corporation, a foreign-owned, for-profit manufacturer of...
<p>The National Heart Lung and Blood Institute awarded a purchase order to Amnis Corporation on January 28, 2011, for maintenance and repair of instruments and laboratory equipment, with a ceiling value of $35,700.00. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of February 6, 2012.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Miltenyi Biotec, Inc. valued at $19,600.00 on October 1, 2012, for maintenance, repair, and rebuild of laboratory instruments and equipment, with an ultimate completion date of September 30, 2013. Place of performance is Bethesda, Maryland. The order is firm fixed-price with no set-aside.</p>
<p>The National Heart Lung and Blood Institute issued a purchase order to Life Technologies Corporation for $7,341.84 on December 9, 2013, with completion on December 9, 2014. The order covers a maintenance agreement, with place of performance in Bethesda, Maryland. Pricing is firm fixed price with no small business set-aside.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Life Technologies Corporation for maintenance services valued at $10,125.40 on July 6, 2017, with an ultimate completion date of July 5, 2018. Performance is located in Bethesda, Maryland. The order covers firm fixed price maintenance support for scientific equipment. No set-aside was applied.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to EMD Millipore Corp for a Milli-Q IQ 7000 purification system on June 22, 2021, with a ceiling value of $14,004.90 and completion date of September 30, 2021. The order is firm fixed price with no set-aside. Performance takes place in Burlington, Massachusetts. The procurement was designated under the Coronavirus COVID-19 National Interest Action Code.</p>